Breast Cancer Screening With MRI in Women Aged 50-75 Years With Extremely Dense Breast Tissue: the DENSE Trial

NACompletedINTERVENTIONAL
Enrollment

40,373

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

April 30, 2023

Study Completion Date

April 30, 2023

Conditions
Breast Cancer
Interventions
OTHER

Contrast enhanced breast MRI

Gadolinium contrast is administered as a bolus with a standard dose of 0.1 mL/kg followed by a saline flush of 30 mL.

Trial Locations (9)

Unknown

Jeroen Bosch Hospital, 's-Hertogenbosch

Hospital Group Twente (ZGT), Almelo

Antoni van Leeuwenhoek Hospital, Amsterdam

VU University Medical Center, Amsterdam

Albert Schweitzer Hospital, Dordrecht

Hospital Group Twente (ZGT), Hengelo

Maastricht University Medical Center, Maastricht

Radboud University Medical Center, Nijmegen

UMC Utrecht, Utrecht

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Dutch Breast Cancer Screening Organisations

UNKNOWN

collaborator

Dutch Reference Centre for Screening

UNKNOWN

collaborator

National Institute for Public Health and the Environment (RIVM)

OTHER_GOV

collaborator

The Netherlands Cancer Institute

OTHER

collaborator

University Medical Center Nijmegen

OTHER

collaborator

Jeroen Bosch Ziekenhuis

OTHER

collaborator

Albert Schweitzer Hospital

OTHER

collaborator

Hospital Group Twente (ZGT)

UNKNOWN

collaborator

Amsterdam UMC, location VUmc

OTHER

collaborator

Maastricht University Medical Center

OTHER

collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

collaborator

Dutch Cancer Society

OTHER

collaborator

Pink Ribbon Inc.

INDUSTRY

collaborator

A Sister's Hope

OTHER

collaborator

Bayer

INDUSTRY

collaborator

Stichting Kankerpreventie Midden-West

UNKNOWN

collaborator

Volpara Solutions

OTHER

lead

UMC Utrecht

OTHER